SCHEMBL30402974

SCHEMBL30402974

C[C@@H]1CN(c2ccc(F)c(C3CC3)c2)CCO1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GPER1 Q99527 1/20 0.39
▸ PDE2A O00408 1/20 0.39
▸ PDE3B Q13370 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ SIGMAR1 Q99720 2/20 0.37
▸ PIM3 Q86V86 1/20 0.36
▸ PIM2 Q9P1W9 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36
▸ PRKDC P78527 2/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ ATM Q13315 6/20 0.35
▸ PIK3C3 Q8NEB9 2/20 0.35
▸ ATR Q13535 1/20 0.35
▸ SYK P43405 1/20 0.35
▸ FFAR2 O15552 1/20 0.35
▸ AKT1 P31749 1/20 0.34
▸ NOTUM Q6P988 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26633120 0.81 PDE3B (0.40) GPER1PDE2APDE3BPDE3ALRRK2
SCHEMBL24196343 0.81 FFAR2 (0.40) GPER1PDE3BPDE3ALRRK2PRKDC
SCHEMBL30403514 0.81 PDE3B (0.40) GPER1PDE2APDE3BPDE3ALRRK2
SCHEMBL24196345 0.81 FFAR2 (0.40) GPER1PDE3BPDE3ALRRK2PRKDC
SCHEMBL29049683 0.81 DRD3 (0.44) GPER1PDE3BPDE3APIM3PIM2
SCHEMBL29049699 0.78 GLRA1 (0.42) GPER1PDE3BPDE3ALRRK2PRKDC
SCHEMBL26633127 0.78 GLRA1 (0.42) GPER1PDE3BPDE3ALRRK2PRKDC
SCHEMBL26633138 0.76 GPER1 (0.38) GPER1PDE3BPDE3APIM3PIM2
SCHEMBL26633115 0.76 GPER1 (0.38) GPER1PDE3BPDE3APIM3PIM2
SCHEMBL32933182 0.75 ATM (0.33) PDE3BPDE3APRKDCATMPIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116171276-A 3- ((1H-pyrazol-4-yl) methyl) -6'- (phenyl) -2H- [1,2' -bipyridin ] -2-one derivatives and related compounds as GRP139 antagonists in methods of treating E.G. depression 武田药品工业株式会社 2023-05-26 — — CN disclosed
Send feedback